pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
HUB-101
Leber Congenital Amaurosis (LCA)
Hubble Therapeutics Inc
0
catalysts
Preclinical
IBP-1118
arginyl-glutamine
Retinopathy Of Prematurity
Infant Bacterial Therapeutics AB
0
catalysts
Phase 2
IC-265
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
0
catalysts
Phase 2
IC-270
Allergic Conjunctivitis
← prev
page 6 of 13
next →
131
Pain
89
Neurology
1
IACTA Pharmaceuticals Inc
0
catalysts
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
0
catalysts
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
0
catalysts
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
0
catalysts
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
0
catalysts
Preclinical
IVW-1802
Myopia
iView Therapeutics Inc
0
catalysts
Preclinical
JV-MD2 (Omega-3)
Retinopathy Of Prematurity
Jenivision Inc (Inactive)
0
catalysts
Phase 3
K-161
Keratoconjunctivitis Sicca (Dry Eye)
Kowa Co Ltd
0
catalysts
Phase 2
KB-801
Neurotrophic Keratitis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Preclinical
KRZQ-028
Graves' Ophthalmopathy
Chongqing Kerun Biopharm R & D Co Ltd
0
catalysts
Preclinical
KRZQ-035
Glaucoma
Chongqing Kerun Biopharm R & D Co Ltd
0
catalysts
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
0
catalysts
Preclinical
Kuragenx
Neurotrophic Keratitis
Pandorum Technologies Pvt Ltd
0
catalysts
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
0
catalysts
Preclinical
LSC Exosome Eye Injection
Age Related Macular Degeneration
$YDES
YD Bio Ltd
0
catalysts
Preclinical
Lead Program
Corneal Degeneration
2A Biosciences Inc
0
catalysts
Preclinical
MC-16
Retinitis Pigmentosa (Retinitis)
Mitochem Therapeutics, LLC
0
catalysts
Preclinical
MCR-231
Neurotrophic Keratitis
MicroCures Inc
0
catalysts
Phase 2
MHB-018A
Graves' Ophthalmopathy
Minghui Pharmaceutical (Shanghai) Co Ltd
0
catalysts
Preclinical
MP-004
Retinitis Pigmentosa (Retinitis)
MIRAMOON Pharma SL
0
catalysts
Preclinical
MSC-2
Optic Neuritis
SanBio Co Ltd
0
catalysts
Marketed
Maxitrol
Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate Sandoz ((dexamethasone + neomycin sulfate + polymyxin B [INN]))
Anterior Segment Inflammation
Sandoz Inc
0
catalysts
Marketed
Miostat
Miostat (carbachol [INN])
Miosis
$NVS
NOVARTIS AG
0
catalysts
Preclinical
N-0651
Age Related Macular Degeneration
Naegis Pharmaceuticals Inc
0
catalysts
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
0
catalysts
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
0
catalysts
Preclinical
NOD-800
Geographic Atrophy
Nanoscope Therapeutics Inc
0
catalysts
